Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: May 25, 2017

DrugPatentWatch Database Preview

Cromolyn sodium - Generic Drug Details

« Back to Dashboard

What are the generic sources for cromolyn sodium and what is the scope of cromolyn sodium patent protection?

Cromolyn sodium
is the generic ingredient in seven branded drugs marketed by Actavis Mid Atlantic, Bausch And Lomb, Akorn, Mylan Speciality Lp, Apotex Inc, Perrigo, Pharmascience Inc, Micro Labs Ltd India, Wockhardt, Genera Pharms, Allergan, Blacksmith Brands, Watson Labs, Teva Pharms, Roxane, Hh And P, Alcon, Pack Pharms Llc, King Pfizer, Ucb Inc, King Pharms, and Sanofi Aventis Us, and is included in twenty-eight NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are ten drug master file entries for cromolyn sodium. Sixteen suppliers are listed for this compound.

Summary for Generic Name: cromolyn sodium

Drug Master File Entries: see list10
Suppliers / Packagers: see list16
Bulk Api Vendors: see list53
Clinical Trials: see list926
Patent Applications: see list7,244
Therapeutic Class:Respiratory Tract Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:cromolyn sodium at DailyMed

Pharmacology for Ingredient: cromolyn sodium

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
cromolyn sodium
SOLUTION/DROPS;OPHTHALMIC018155-001Oct 3, 1984DISCNYesNo► Subscribe► Subscribe
Apotex Inc
cromolyn sodium
SOLUTION/DROPS;OPHTHALMIC075615-001Jan 26, 2001DISCNNoNo► Subscribe► Subscribe
King Pharms
cromolyn sodium
SOLUTION;INHALATION018596-001May 28, 1982DISCNNoNo► Subscribe► Subscribe
Actavis Mid Atlantic
cromolyn sodium
SOLUTION;INHALATION075067-001Jul 19, 1999DISCNNoNo► Subscribe► Subscribe
cromolyn sodium
SOLUTION/DROPS;OPHTHALMIC074706-001Apr 29, 1998ATRXNoYes► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Anticipate P&T budget requirements
  • Find generic sources and suppliers
  • Uncover prior art in abandoned patent applications and expired patents

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus